Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 August 2002

Volume 186, Number 3
The Journal of Infectious Diseases 2002;186:410–414
0022-1899/2002/18603-0014$15.00
DOI: 10.1086/341561
CONCISE COMMUNICATION

Evidence of Thymic Function in Heavily Antiretroviral‐Treated Human Immunodeficiency Virus Type 1–Infected Adults with Long‐Term Virologic Treatment Failure

Juan Delgado,1

Manuel Leal,1

Ezequiel Ruiz‐Mateos,1

Manuel Martínez‐Moya,2

Amalia Rubio,1

Elena Merchante,2

Rafael de la Rosa,1

Armando Sánchez‐Quijano,1 and

Eduardo Lissen1

1Viral Hepatitis and AIDS Study Group, Department of Internal Medicine, and 2Department of Radiology, Virgen del Rocío University Hospital, Seville, Spain

Thymic function was evaluated in 32 heavily antiretroviral‐treated human immunodeficiency virus type 1 (HIV‐1)–infected adults with long‐term virologic treatment failure by measuring thymic volume, by determining the absolute number of naive T cell phenotypes, and by determining the number of cells carrying T cell receptor excision circles (TRECs). There was a significant inverse correlation between age and thymic volume ( ; ), and there was a significant direct correlation between thymic volume and total naive T cell counts ( ; ), naive CD4+ cell counts ( ; ), naive CD8+ cell counts ( ; ), and TREC levels ( ; ). In conclusion, this study found clear evidence that the thymus of heavily antiretroviral‐treated HIV‐1–infected adults with long‐term virologic treatment failure is actively engaged in thymopoiesis, which generates new naive T cells for the peripheral lymphocyte pool.

Received 16 November 2001; revised 5 April 2002; electronically published 5 July 2002.

Reprints or correspondence: Dr. Manuel Leal, Grupo Estudio Hepatitis Virica y SIDA, Dept. of Internal Medicine, Virgen del Rocío University Hospital, Avda, Manuel Siurot s/n, 41011 Seville, Spain ().

Cited by

Raphael Ho Tsong Fang, Arnaud D Colantonio, Christel H Uittenbogaart. (2008) The role of the thymus in HIV infection: a 10 year perspective. AIDS 22:2, 171-184
Online publication date: 1-Feb-2008.
CrossRef
Robert C. Kalayjian, John Spritzler, Minya Pu, Alan Landay, Richard B. Pollard, Vicki Stocker, Lena‐Al Harthi, Barry H. Gross, Isaac R. Francis, Susan A. Fiscus, Pablo Tebas, Ronald J. Bosch, Victor Valcour, and Michael M. Lederman, for the Adult AIDS Clinical Trials Group 5015 and 5113 Study Teams. (2005) Distinct Mechanisms of T Cell Reconstitution Can Be Identified by Estimating Thymic Volume in Adult HIV‐1 Disease. The Journal of Infectious Diseases 192:9, 1577-1587
Online publication date: 1-Nov-2005.
Berta Rodes, Federico García, Carolina Gutierrez, Javier Martinez-Picado, Antonio Aguilera, Maria Saumoy, Alex Vallejo, Pere Domingo, David Dalmau, Maria Angels Ribas, José Luis Blanco, José Pedreira, Maria Jesús Perez-Elias, Manuel Leal, Carmen de Mendoza, Vincent Soriano, . (2005) Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients. Journal of Medical Virology 77:1, 23-28
Online publication date: 1-Oct-2005.
CrossRef
Carlo Torti, Giuliana Cologni, Maria Cristina Uccelli, Eugenia Quiros-Roldan, Luisa Imberti, Paolo Airo, Silvia Pirovano, Andrea Patroni, Valeria Tirelli, Giampiero Carosi. (2004) Immune Correlates of Virological Response in HIV-Positive Patients after Highly Active Antiretroviral Therapy (HAART). Viral Immunology 17:2, 279-286
Online publication date: 1-Jul-2004.
CrossRef
M.A. French, S.R. Lewin, C. Dykstra, R. Krueger, P. Price, P.J. Leedman. (2004) Graves' Disease During Immune Reconstitution After Highly Active Antiretroviral Therapy for HIV Infection: Evidence of Thymic Dysfunction. AIDS Research and Human Retroviruses 20:2, 157-162
Online publication date: 1-Mar-2004.
CrossRef
Giota Touloumi, Nikos Pantazis, Anastasia Karafoulidou, Titika Mandalaki, James J. Goedert, Leondios G. Kostrikis, Angelos Hatzakis. (2004) Changes in T Cell Receptor Excision DNA Circle (TREC) Levels in HIV Type 1-Infected Subjects Pre- and Post-Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses 20:1, 47-54
Online publication date: 1-Feb-2004.
CrossRef
  • This study was designed and performed according to the Helsinki Declaration and was approved by the Ethical Committee of the University Hospital Virgen del Rocío of Seville (Spain). All patients gave written informed consent to participate in this cross‐sectional study.

    Financial support: Fondo de Investigaciones Sanitarias (FIS 00/0521); Fondo para la Investigación y Prevención del SIDA en España (FIPSE 2132/00, including Ministerio de Sanidad y Consumo, Abbott Laboratories, Boehringer Ingelgeim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme, and Roche); Fundación Wellcome España.

Close Popup